Danaher Corporation $DHR Stock Position Reduced by Huntington National Bank

Huntington National Bank lessened its position in shares of Danaher Corporation (NYSE:DHR) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 45,031 shares of the conglomerate’s stock after selling 3,493 shares during the period. Huntington National Bank’s holdings in Danaher were worth $10,309,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of DHR. JPL Wealth Management LLC bought a new position in Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new position in Danaher during the 4th quarter worth approximately $26,000. WFA of San Diego LLC bought a new position in Danaher during the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners bought a new position in Danaher during the 3rd quarter worth approximately $32,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 4.2%

Shares of Danaher stock opened at $180.47 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The business’s 50 day simple moving average is $182.29 and its 200-day simple moving average is $207.65. The stock has a market capitalization of $127.73 billion, a price-to-earnings ratio of 34.91, a PEG ratio of 2.31 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period last year, the firm earned $1.88 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. Equities research analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analysts Set New Price Targets

A number of research analysts have commented on the company. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Robert W. Baird dropped their price target on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research report on Friday, April 17th. Argus dropped their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Finally, Wolfe Research dropped their price target on Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $238.24.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.